PatientsVille.com Logo

PatientsVille

Aspegic Side Effects

Common Aspegic Side Effects


The most commonly reported Aspegic side effects (click to view or check a box to report):

Alanine Aminotransferase Increased (4)
Toxic Epidermal Necrolysis (4)
Thrombocytopenia (4)
Aspartate Aminotransferase Increased (4)
Coma (3)
Gamma-glutamyltransferase Increased (3)
Pruritus (3)
Renal Failure Acute (3)
Rash (3)
Glomerulonephropathy (2)
Abdominal Pain (2)
Blood Alkaline Phosphatase Increased (2)
Loss Of Consciousness (2)
Aphasia (2)
Subarachnoid Haemorrhage (2)
Somnolence (2)
Skin Test Negative (2)
Pyrexia (2)
Purpura (2)
Prothrombin Level Decreased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Aspegic Side Effects Reported to FDA

The following Aspegic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Aspegic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Confusional State, Hallucination
This is a report of a 88-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: prophylaxis,hypersensitivity, who was treated with Aspegic (dosage: NA, start time: NS), combined with:
  • Telfast
  • Plavix
  • Lamaline
  • Lyrica
  • Travatan
  • Trusopt
  • Fluoxetine
  • Ventoline
and developed a serious reaction and side effect(s). The consumer presented with:
  • Confusional State
  • Hallucination
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic treatment in female patients, resulting in confusional state side effect. The patient was hospitalized.

Hepatocellular Injury, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Rash
This report suggests a potential Aspegic Hepatocellular Injury, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Rash side effect(s) that can have serious consequences. A 77-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Aspegic (dosage: NA) starting Jan 30, 2013. Soon after starting Aspegic the patient began experiencing various side effects, including:
  • Hepatocellular Injury
  • Aspartate Aminotransferase Increased
  • Alanine Aminotransferase Increased
  • Pyrexia
  • Gamma-glutamyltransferase Increased
  • Blood Alkaline Phosphatase Increased
  • Abdominal Pain
  • Rash
Drugs used concurrently:
  • Plavix
  • Lovenox
  • Lasilix
  • Tahor (Strength: 80 Mg)
  • Umuline
  • Loxen (Strength: 10 Mg/10 Ml)
  • Eupantol
  • Phloroglucinol
The patient was hospitalized. Although Aspegic demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hepatocellular injury, may still occur.

Anaemia
This Anaemia problem was reported by a health professional from FR. A 84-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Aspegic (dosage: NA). The following drugs were being taken at the same time:
  • Plavix
  • Amiodarone
When commencing Aspegic, the patient experienced the following unwanted symptoms/side effects:
  • Anaemia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as anaemia, may become evident only after a product is in use by the general population.

Splenic Haemorrhage
This is a report of a 44-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: cerebrovascular accident and was treated with Aspegic 1000 (dosage: 1 Df, 1x/day) starting May 04, 2012. Concurrently used drugs:
  • Orgaran (1 Df, 2x/day)
  • Argatroban (2.4 Ml/hr)
Soon after that, the consumer experienced the following side effects:
  • Splenic Haemorrhage
This opens a possibility that Aspegic 1000 treatment could cause the above reactions, including splenic haemorrhage, and some female subjects may be more susceptible.


Altered State Of Consciousness, Encephalopathy
A male patient (weight: NA) from FRANCE with the following symptoms/conditions: NA started Aspegic 1000 treatment (dosage: NA) on Nov 21, 2011. Soon after starting Aspegic 1000 treatment, the subject experienced various side effects, including:
  • Altered State Of Consciousness
  • Encephalopathy
Concurrently used drugs:
  • Pegasys (Dosage Form: Solution For Injection, On Each Mondays)
  • Acetaminophen (One Hour Before Pegasys* Injection)
  • Incivo (telaprevir) (Dosage Form: Tablet)
  • Copegus (200 Mg : 2-0-3)
  • Atorvastatin
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Aspegic 1000.

Pyelonephritis, Infection
A 72-year-old female patient from TUNISIA (weight: NA) experienced symptoms, such as: NA and was treated with Aspegic 1000(dosage: NA). The treatment was initiated on Jul 10, 2011. After that a consumer reported the following side effect(s):
  • Pyelonephritis
  • Infection
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Aspegic 1000 efficacy:
  • Insulatard Nph Human
  • Plavix
  • Atorvastatin Calcium
  • Ramipril
  • Lasix


Thrombophlebitis Superficial
In this report, Aspegic 1000 was administered for the following condition: NA.A 65-year-old male consumer from FRANCE (weight: NA) started Aspegic 1000 treatment (dosage: 250 Mg (500 Mg/5 Ml), Daily) on Apr 11, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Thrombophlebitis Superficial
A possible interaction with other drugs could have contributed to this reaction:
  • Nicotine
  • Novomix
  • Pantoprazole (40 Mg, Daily)
  • Insulin (Unk)
  • Lovenox (40 Mg, Unk)
  • Lexomil
  • Atorvastatin (40 Mg, Daily)
  • Sodium Chloride (1000 Mg, Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Aspegic 1000 treatment could be related to the listed above side effect(s).

Cerebral Haematoma
This is a report of the following Aspegic 1000 side effect(s):
  • Cerebral Haematoma
A 77-year-old male patient from FRANCE (weight: NA) presented with the following condition: NA and received a treatment with Aspegic 1000 (dosage: NA) starting: Apr 06, 2012.The following concurrently used drugs could have generated interactions:
  • Budesonide/formoterol Fumarate (Strength; 400/12 Mcg, Form; Powder For Inhalation)
  • Heparin Sodium
  • Aspirin
  • Lercanidipine (Strength; 20 Mg)
  • Orbenin Cap
  • Spiriva (Strength; 18 Mcg)
  • Amoxicillin
  • Plavix
The patient was hospitalized.This report suggests that a Aspegic 1000 treatment could be associated with the listed above side effect(s).

Subarachnoid Haemorrhage, Coma
This Aspegic 325 report was submitted by a 68-year-old female consumer from FRANCE (weight: NA). The patient was diagnosed with: acute coronary syndrome and Aspegic 325 was administered (dosage: 250mg Per Day) starting: Nov 01, 2011. The consumer developed a set of symptoms:
  • Subarachnoid Haemorrhage
  • Coma
Other drugs used simultaneously:
  • Arixtra (2.5mg Per Day)
Those unexpected symptoms could be linked to a Aspegic 325 treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Hypoglycaemia, Maternal Exposure During Pregnancy
This is a report of a possible correlation between Aspegic 1000 use and the following symptoms/side effect(s):
  • Hypoglycaemia
  • Maternal Exposure During Pregnancy
which could contribute to an assessment of Aspegic 1000 risk profile.A 31-year-old female consumer from ALGERIA (weight: NA) was suffering from platelet aggregation inhibition and was treated with Aspegic 1000 (dosage: 100 Mg, Qd (before Pregnancy Starts)) starting NS.Other concurrent medications:
  • Daflon /00426001/ (2 Tab, Qd (during 2nd Trimester Of Pregnancy))
  • Novorapid Flexpen (3 Injections Of 06 Iu)
  • Insulatard Penfill (1 Injection Of 06 Ui)


Thrombocytopenia, Renal Failure Acute
A 90-year-old female patient from FRANCE (weight: NA) presented with the following symptoms: NA and after a treatment with Aspegic 325 (dosage: Unk) experienced the following side effect(s):
  • Thrombocytopenia
  • Renal Failure Acute
The treatment was started on Dec 22, 2011. Aspegic 325 was used in combination with the following drugs:
  • Acetaminophen (Unk)
  • Ofloxacin (400 Mg, Daily)
  • Ceftriaxone Sodium (1 G, Unk)
  • Lasix (Unk)
  • Pantoprazole (20 Mg, Daily)
  • Enoxaparin Sodium (1 Df, Unk)
  • Arimidex
  • Deroxat (Unk)
This report could alert potential Aspegic 325 consumers.

Skin Test Negative, Toxic Epidermal Necrolysis
In this report, a 9-year-old female patient from FRANCE (weight: NA) was affected by a possible Aspegic 325 side effect.The patient was diagnosed with pyrexia. After a treatment with Aspegic 325 (dosage: 1 Df, Single, start date: Oct 30, 2010), the patient experienced the following side effect(s):
  • Skin Test Negative
  • Toxic Epidermal Necrolysis
The following simultaneously used drugs could have led to this reaction:
  • Acetaminophen (1 Df, Single)
  • Ibuprofen (advil) (1 Df, Single)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Aspegic 325 treatment.

Subarachnoid Haemorrhage, Coma
This is a report of a 68-year-old female patient from FRANCE (weight: NA), who used Aspegic 325 (dosage: 250mg Per Day) for a treatment of acute coronary syndrome. After starting a treatment on Nov 01, 2011, the patient experienced the following side effect(s):
  • Subarachnoid Haemorrhage
  • Coma
The following drugs could possibly have interacted with the Aspegic 325 treatment
  • Arixtra (2.5mg Per Day)
Taken together, these observations suggest that a Aspegic 325 treatment could be related to side effect(s), such as Subarachnoid Haemorrhage, Coma.

Skin Test Negative, Toxic Epidermal Necrolysis
This skin test negative side effect was reported by a health professional from FRANCE. A 9-year-old female patient (weight:NA) experienced the following symptoms/conditions: pyrexia. The patient was prescribed Aspegic 325 (dosage: 1 Df, Single), which was started on Oct 30, 2010. Concurrently used drugs:
  • Acetaminophen (1 Df, Single)
  • Ibuprofen (advil) (1 Df, Single)
When starting to take Aspegic 325 the consumer reported the following symptoms:
  • Skin Test Negative
  • Toxic Epidermal Necrolysis
The patient was hospitalized. These side effects may potentially be related to Aspegic 325.

Rash Papular, Pruritus
This is a Aspegic 325 side effect report of a 50-year-old male patient (weight:NA) from FRANCE, suffering from the following symptoms/conditions: NA, who was treated with Aspegic 325 (dosage:100 Mg, 1x/day, start time: Oct 19, 2011), combined with:
  • Perindopril Erbumine (1 Mg, 1x/day)
  • Sectral (Unk)
  • Atorvastatin Calcium (80 Mg, 1x/day)
  • Plavix (75 Mg, 1x/day)
  • Plavix (75 Mg, 2x/week)
, and developed a serious reaction and a rash papular side effect. The patient presented with:
  • Rash Papular
  • Pruritus
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Aspegic 325 treatment in male patients suffering from NA, resulting in rash papular.

Dry Skin, Psoriasis
This report suggests a potential Aspegic 325 dry skin side effect(s) that can have serious consequences. A male patient from FRANCE (weight:NA) was diagnosed with the following health condition(s): platelet aggregation inhibition,prophylaxis against transplant rejection and used Aspegic 325 (dosage: NA) starting Dec 01, 2005. Soon after starting Aspegic 325 the patient began experiencing various side effects, including:
  • Dry Skin
  • Psoriasis
Drugs used concurrently:
  • Prograf
  • Mycophenolate Mofetil (cellcept)
  • Pantoprazole Sodium
  • Tacrolimus (2 Mg, Uid/qd)
  • Lamivudine
  • Prazosin Hcl
  • Prazepam
Although Aspegic 325 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dry skin, may still occur.

Renal Failure Acute
This renal failure acute problem was reported by a consumer or non-health professional from TUNISIA. A 77-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Oct 20, 2011 a consumer started treatment with Aspegic 325 (dosage: NA). The following drugs/medications were being taken at the same time:
  • Plavix
  • Atorvastatin
  • Insulin
  • Plavix
When commencing Aspegic 325, the patient experienced the following unwanted symptoms /side effects:
  • Renal Failure Acute
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as renal failure acute, may become evident only after a product is in use by the general population.

Coagulation Factor V Level Decreased, Alanine Aminotransferase Increased, Neutrophil Count Increased, White Blood Cell Count Increased, Gamma-glutamyltransferase Increased, Blood Creatine Phosphokinase Increased, Prothrombin Time Prolonged, Activated Partial Thromboplastin Time Prolonged, Aspartate Aminotransferase Increased
This is a Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) side effect report of a 81-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: NA and was treated with Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) (dosage: NA) starting May 01, 2011. Concurrently used drugs:
  • Kardegic (acetylsalicylic Lysine, Acetylsalicylic Acid)
  • Mupiderm (mupirocin)
  • Spironolactone
  • Nitroglycerin Spray
  • Dexeryl (glycerol, Paraffin, Liquid, White Soft Paraffin)
  • Ginkor Fort (ginkgo Biloba, Heptaminol Hydrochloride, Troxerutin)
  • Morphine
  • Fixical (calcium Carbonate)
Soon after that, the consumer experienced the following of symptoms:
  • Coagulation Factor V Level Decreased
  • Alanine Aminotransferase Increased
  • Neutrophil Count Increased
  • White Blood Cell Count Increased
  • Gamma-glutamyltransferase Increased
  • Blood Creatine Phosphokinase Increased
  • Prothrombin Time Prolonged
  • Activated Partial Thromboplastin Time Prolonged
  • Aspartate Aminotransferase Increased
The patient was hospitalized. This opens a possibility that Aspegic (acetylsalicylate Lysine, Aminoacetic Acid) could cause coagulation factor v level decreased and that some female patients may be more susceptible.

Gastrointestinal Angiodysplasia, Rectal Haemorrhage
A 79-year-old female patient (weight: NA) from FRANCE with the following symptoms: ischaemic cardiomyopathy,atrial fibrillation started Aspegic 325 treatment (dosage: NA) on Oct 01, 2011. Soon after starting Aspegic 325 treatment, the consumer experienced several side effects, including:
  • Gastrointestinal Angiodysplasia
  • Rectal Haemorrhage
. Concurrently used drugs:
  • Pradaxa (220 Mg)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Aspegic 325 side effects, such as gastrointestinal angiodysplasia.

Cardiac Perforation, Cardiac Tamponade
This cardiac perforation side effect was reported by a physician from SWITZERLAND. A male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Aspegic 325 (dosage: 500 Mg, Unk), which was started on Apr 16, 2011. Concurrently used drugs:
  • Prasugrel Hydrochloride (60 Mg, Loading Dose)
  • Perlinganit (4 Mg/h)
.When starting to take Aspegic 325 the consumer reported symptoms, such as:
  • Cardiac Perforation
  • Cardiac Tamponade
These side effects may potentially be related to Aspegic 325. The patient was hospitalized.


This is a report of a 71-year-old female patient (weight: NA) from TUNISIA, suffering from the following symptoms/conditions: NA, who was treated with Aspegic 325 (dosage: NA, start time: Dec 25, 2010), combined with:
  • Plavix
  • Glucophage
  • Glyburide
  • Plavix
  • Captopril
  • Fenofibrate
and developed a serious reaction and side effect(s). The consumer presented with:
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Aspegic 325 treatment in female patients, resulting in sudden death side effect.

    Coagulation Factor V Level Decreased, Prothrombin Level Decreased
    This report suggests a potential Aspegic (acetylsalicylate Lysine) Coagulation Factor V Level Decreased, Prothrombin Level Decreased side effect(s) that can have serious consequences. A 48-year-old male patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: NA and used Aspegic (acetylsalicylate Lysine) (dosage: NA) starting Sep 11, 2009. Soon after starting Aspegic (acetylsalicylate Lysine) the patient began experiencing various side effects, including:
    • Coagulation Factor V Level Decreased
    • Prothrombin Level Decreased
    Drugs used concurrently:
    • Lovenox
    • Crestor
    • Isosorbide Dinitrate
    • Nicopatch (nicotine)
    • Atenolol
    • Plavix
    • Angiomax (1 Mg/kg, Bolus, Intravenous, 0.25 Mg/kg, Hr, Intravenous)
    • Angiomax (1 Mg/kg, Bolus, Intravenous, 0.25 Mg/kg, Hr, Intravenous)
    Although Aspegic (acetylsalicylate Lysine) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as coagulation factor v level decreased, may still occur.

    Convulsion, Fall, Inappropriate Antidiuretic Hormone Secretion, Haematoma
    This Convulsion, Fall, Inappropriate Antidiuretic Hormone Secretion, Haematoma problem was reported by a physician from FRANCE. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Sep 16, 2000 this consumer started treatment with Aspegic 250 (dosage: NA). The following drugs were being taken at the same time:
    • Lasix
    • Lactulose
    • Paroxetine Hcl
    • Digoxin
    • Nitroderm
    • Levothyroxine Sodium
    • Haldol (5drop Per Day)
    • Acetaminophen W/ Propoxyphene Hcl
    When commencing Aspegic 250, the patient experienced the following unwanted symptoms/side effects:
    • Convulsion
    • Fall
    • Inappropriate Antidiuretic Hormone Secretion
    • Haematoma
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as convulsion, may become evident only after a product is in use by the general population.

    Weight Decreased, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Abdominal Pain, Diarrhoea, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Mixed Liver Injury, Dyspepsia
    This is a report of a male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: myocardial ischaemia and was treated with Aspegic 325 (dosage: 100 Mg Per Day, Unk) starting Dec 01, 2009. Concurrently used drugs:
    • Lanzor (30 Mg Per Day, Unk)
    • Diltiazem Hcl (60 Mg, Qid)
    • Corvasal (4 Mg, Qid)
    • Atorvastatin Calcium (20 Mg, Unk)
    • Atorvastatin Calcium (80 Mg, Unk)
    • Amlodipine (Unk Ukn, Unk)
    • Ikorel (10 Mg Per Day, Unk)
    • Rasilez (300 Mg, Qd)
    Soon after that, the consumer experienced the following side effects:
    • Weight Decreased
    • Alanine Aminotransferase Increased
    • Blood Alkaline Phosphatase Increased
    • Abdominal Pain
    • Diarrhoea
    • Aspartate Aminotransferase Increased
    • Gamma-glutamyltransferase Increased
    • Mixed Liver Injury
    • Dyspepsia
    The patient was hospitalized. This opens a possibility that Aspegic 325 treatment could cause the above reactions, including weight decreased, and some male subjects may be more susceptible.

    Aggression, Suicidal Ideation, Irritability, Depression
    A male patient (weight: NA) from FRANCE with the following symptoms/conditions: systemic lupus erythematosus,epilepsy started Aspegic 325 treatment (dosage: NA) on Jan 01, 2010. Soon after starting Aspegic 325 treatment, the subject experienced various side effects, including:
    • Aggression
    • Suicidal Ideation
    • Irritability
    • Depression
    Concurrently used drugs:
    • Keppra
    • Trileptal
    • Plaquenil
    This finding indicates that some male patients could be more vulnerable to Aspegic 325.

    1 of 3 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Aspegic Side Effects

    Did You Have a Aspegic Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Aspegic for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Aspegic Safety Alerts, Active Ingredients, Usage Information

    More About Aspegic

    Side Effects reported to FDA: 51

    Aspegic safety alerts: No

    Reported deaths: 5

    Reported hospitalizations: 16

    Latest Aspegic clinical trials